Episode Details

Back to Episodes
GLP-1 Drugs Linked to Hair Loss Risk | UK News

GLP-1 Drugs Linked to Hair Loss Risk | UK News

Published 4 days, 18 hours ago
Description

New research links popular weight loss drugs like Ozempic and Mounjaro to a 68% higher risk of hair loss compared to other diabetes meds, based on data from over 50,000 people. While the exact cause isn’t clear—possibly tied to rapid weight loss triggering nutrient deficiencies or direct metabolic effects—the findings are prompting regulators in the U.S. and U.K. to investigate. Though hair loss may not be life-threatening, it can significantly impact mental health and self-esteem. Experts stress that the drugs’ benefits for diabetes and obesity still outweigh this side effect for most users, but awareness is key as more data emerges.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/9a1d5dba1aef236c

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us